EP3054937
SPRAY DRY FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.10.2014EP published:
26.7.2023EP application number:
14852309.5
EPO information:
European Patent Register
Max expiry date:
9.10.2034
Title in English:
SPRAY DRY FORMULATIONSLanguage of the patent:
English
Timeline
Today
10.10.2014EP application
26.7.2023EP Publication
Owner
Name:
Pulmokine, Inc.Address:
7 University Place, Lab Location - RM B127, Rensselaer, NY 12144, US
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Inventor
Name:
ZISMAN, Lawrence, S.Address:
New York 12159, US
Priority
Number:
201361889887 PDate:
11.10.2013Country:
US
Classification
Categories:
A61K 31/497, A61K 9/00, A61P 11/00